MHRA Drug Safety Update December 2022
MHRA Drug Safety Update December 2022
Posted: Tuesday, December 13, 2022
Category - Medicines Update
GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for further information and here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.
Posted: Tuesday, December 13, 2022
Category - Medicines Update
MHRA Drug Safety Update December 2022
Posted: Friday, December 2, 2022
Category - Medicines Update
Posted: Friday, December 2, 2022
Category - Medicines Update
Posted: Friday, December 2, 2022
Category - Medicines Update
MHRA Drug Safety Update November 2022
Posted: Friday, December 2, 2022
Category - Medicines Update
Posted: Monday, November 14, 2022
Category - Medicines Update
Metformin can commonly reduce vitamin B12 levels in patients, which may lead to vitamin B12 deficiency. Refer to MHRA Drug Safety Update here.
B12 deficiency risk increases with higher metformin doses, longer treatment duration and patients with a risk of B12 deficiency (see below for additional risk factors)
Posted: Monday, October 31, 2022
Category - Medicines Update
Key messages
Posted: Wednesday, October 12, 2022
Category - Medicines Update
Guideline News September 2022
Posted: Wednesday, August 10, 2022
Category - Medicines Update
Guideline News for July 2022
Posted: Wednesday, August 3, 2022
Category - Medicines Update
Metronidazole has excellent oral bioavailability reaching 95-100%.
NHSGGC Adult Infection Management Guidelines were updated to include the option of oral metronidazole in the management of intra-abdominal sepsis (IAS) and diabetic foot infection.